Asking the right questions is key to giving pharmaceutical industry contract managers the information they need to select the best CRO partners according to the team behind a new performance assessment project.
Charles River Laboratories (CRL) continued to experience low demand for preclinical services in Q3, while Covance's early-phase business saw revenue growth.
Quintiles says it will buy US bioanalytical lab Advion BioServices citing a pharmaceutical industry shift towards more thorough laboratory testing as motivation.
Quintiles has bought its way into the observational research space with the acquisition of Outcome Sciences and strengthened its market access standing with the purchase of VCG & Associates.
Securing supply chains and limiting access to manufacturing data can help stop clinical-stage drugs being abused in sport according to UK drug major GSK.
Another day, another prediction the contract research sector is set for growth in 2012 with new analysis suggesting ‘mature’ strategic deals and higher demand will drive earnings.
ACRO has backed plans to reduce the tax rate on foreign earnings sent back to the US, arguing that the move would create jobs in the contract research sector.
Outsourcing-pharma.com presents a roundup of deals in the contract research space with acquisitions by Aptiv and Eurofins, another partnership for Spaulding and fundraising by Clinipace.
The contract research sector has grown markedly over the last decade, with more drugs being examined in more trials by more researchers according to a new Association of Clinical Research Organisations (ACRO) survey.
Communication was the central theme at Patient Recruitment Outsourcing (PRO) 2011 in Boston, US this week, with attendees agreeing that better dialog between all stakeholders is vital to addressing the trial sector’s perennial recruitment headache.
Early adopters are effectively using social media for patient recruitment and retention but in general the industry is fearful, a panelist at Patient Recruitment Outsourcing (PRO) 2011 said.
The EU Clinical Trials Register (EU-CTR) has been formally recognised by the World Health Organization (WHO) as one of the primary registries for its International Clinical Trials Registry Platform (ICTRP).
Anti-cancer clinical trial specialist, South Texas Accelerated Therapeutics (START), has collaborated with China's largest cancer hospital to open a new Phase I cancer research center.
Clinical trial enrollment can be accelerated by better understanding patients and using EHRs to inform protocol design, panelists told an Outsourcing-Pharma conference.
A new study claims that almost 60 per cent of clinical trial protocols for new drugs are amended during the trial, but one-third of those changes could have been avoided.
Kellman Pharmaceutical Services (KPS) and trial management services firm Y-Prime have put pen to paper in a deal to develop a series of clinical electronic monitor visit reporting (e-MVR) tools.
The Outsourcing-pharma.com team is heading to Boston, Massachusetts for Patient Recruitment Outsourcing – our exciting new US conference and networking event.
US pharmaceutical firm Eli Lilly says taking language, cultural diversity and site location into account helped boost ethnic minority participation in a recently completed trial.
The Russian Ministry of Health (MoH) has cleared nearly 600 trial sites for clinical research, easing concerns that the reaccreditation process was taking too long.
Mid-tier CROs are being squeezed out of the post-marketing sector as sponsors choose providers with more scale or specialisation, market research found.
Drug Developers struggle to find PK-PD providers that are fast and efficient says US CRO ClinPharm Consulting, after launching a new suite of services designed to cut risk and maximize return on R&D investment.
Pharma industry sponsors want more effective ways of measuring CRO performance according to the team behind a new project aiming to develop a validated set of analysis tools.
CRO performance across late stage, Phase I and central laboratories should improve in 2012 as strategic deals develop and smaller clients return, an analyst said.